• BIA Blog

CEO Update|Monday 14 October

The weather may have caused maximum disruption in Japan this week, but not for biotech.

BIA meets FIRM in Japan

At a ceremony last Friday at BIO Japan in Yokohama, the BIA and the Japanese Forum for Innovative Regenerative Medicine (FIRM) exchanged directories of our members operating in the Cell and Gene Therapy space. This exciting new business tool springs from a partnership that was cemented with the signing of a Memorandum of Understanding between the BIA and FIRM earlier in the year. On our side, the work is led by the Cell and Gene Therapy Advisory Committee (CGTAC).

Overcoming the barriers to cell and gene therapies

The last decade has seen significant scientific developments in cell therapies, gene therapies and tissue engineered products, collectively described as ATMPs (Advanced Therapy Medicinal Products). The impact of such treatments could be transformational. As such, we believe it is crucially important to support the sector as it navigates the complex clinical, regulatory, manufacturing, and pricing environments in which it operates.

CEO Update|Monday 07 October 2019

With weeks to go until the 31 Oct Brexit deadline, this week Prime Minister Boris Johnson outlined his latest Brexit proposals, focussed on alternative solutions to the Irish border question.

THE bioprocessing networking event of the year heads to Liverpool this November!

The BIA’s 16th Annual bioProcess UK Conference will be held in Liverpool on the 27-28 November! We will welcome delegates to a city renowned for its culture and arts, as well as being the home to Liverpool Football Club, the current Champions League and Super Cup winners.

Guest Blog | Developing the Life Sciences workforce for a new digitally-driven reality

The Science Industry Partnership (SIP) in collaboration with BIA, ABPI and with the support of the Office for Life Sciences (OLS) can now report on the interim findings of the Life Sciences 2030 Skills Strategy which is building a clear evidence base of the status of life science skills and future scenarios to 2030.

CEO Update | Monday 30 September 2019

This week’s blog focuses on BIA advocacy in full swing at both European Biotech week and at the UK political party conferences, more Brexit preparedness and a fantastic Women in Biotech event.

CEO Update | Monday 23 September 2019

This week is European Biotech Week, a celebration of biotechnology with more than 130 events taking place in over 17 countries.

Seven new data hubs improve clinical outcomes for UK patients

Earlier this month we heard the announcement for the creation of seven new data hubs to be rolled out across the UK.

CEO Update | Monday 16 September 2019

Last week hidden beneath the Government's announcement that students will be able to stay in the UK for two years, there were developments on the UK life science industrial strategy, which the BIA has partnered with government on for the last three years.